date,title,source
Oct-31-18,"Flexion Therapeutics to Report Third-Quarter 2018 Financial Results on November 7, 2018",GlobeNewswire
Nov-07-18,"Flexion Therapeutics (FLXN) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Flexion Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights,GlobeNewswire
Nov-08-18,Edited Transcript of FLXN earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-16-18,Flexion Therapeutics Named Top Place to Work for Second Consecutive Year by The Boston Globe,GlobeNewswire
Nov-27-18,Flexion Therapeutics Inc (NASDAQ:FLXN): What Does Its Beta Value Mean For Your Portfolio?,Simply Wall St.
Nov-27-18,"New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-28-18,2 Small Biotech Stocks That Insiders Are Buying,TheStreet.com
Dec-04-18,Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),GlobeNewswire
Dec-11-18,Here's Why Flexion Therapeutics Jumped 20.5% in November,Motley Fool
Dec-20-18,"Flexion Therapeutics to Report Preliminary Unaudited 2018 Revenue and Provide 2019 Revenue Guidance on January 3, 2019",GlobeNewswire
Jan-03-19,Flexion shares plummet after weak revenue guidance,MarketWatch
